PMC:7105881 / 55781-56097 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1710","span":{"begin":29,"end":33},"obj":"Species"},{"id":"1711","span":{"begin":41,"end":49},"obj":"Species"},{"id":"1713","span":{"begin":218,"end":236},"obj":"Disease"}],"attributes":[{"id":"A1710","pred":"tao:has_database_id","subj":"1710","obj":"Tax:10090"},{"id":"A1711","pred":"tao:has_database_id","subj":"1711","obj":"Tax:1335626"},{"id":"A1713","pred":"tao:has_database_id","subj":"1713","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T320","span":{"begin":191,"end":199},"obj":"Body_part"}],"attributes":[{"id":"A320","pred":"fma_id","subj":"T320","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}

{"project":"LitCovid_AGAC","denotations":[{"id":"p63268s31","span":{"begin":164,"end":190},"obj":"MPA"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T271","span":{"begin":227,"end":236},"obj":"Disease"}],"attributes":[{"id":"A271","pred":"mondo_id","subj":"T271","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T651","span":{"begin":39,"end":40},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T652","span":{"begin":71,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T112","span":{"begin":125,"end":150},"obj":"http://purl.obolibrary.org/obo/GO_0002456"},{"id":"T113","span":{"begin":125,"end":150},"obj":"http://purl.obolibrary.org/obo/GO_0002449"},{"id":"T114","span":{"begin":125,"end":150},"obj":"http://purl.obolibrary.org/obo/GO_0002443"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T299","span":{"begin":0,"end":316},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T918","span":{"begin":29,"end":33},"obj":"NCBITaxon:10088"},{"id":"T919","span":{"begin":41,"end":49},"obj":"SP_9"},{"id":"T920","span":{"begin":125,"end":133},"obj":"GO:0051716"},{"id":"T921","span":{"begin":134,"end":140},"obj":"UBERON:0002405;GO:0006955"},{"id":"T922","span":{"begin":141,"end":150},"obj":"GO:0006955"},{"id":"T923","span":{"begin":170,"end":177},"obj":"UBERON:0000912"},{"id":"T924","span":{"begin":191,"end":199},"obj":"GO:0042571;GO:0016064"},{"id":"T925","span":{"begin":200,"end":209},"obj":"GO:0016064"},{"id":"T926","span":{"begin":218,"end":226},"obj":"SP_9"},{"id":"T39837","span":{"begin":29,"end":33},"obj":"NCBITaxon:10088"},{"id":"T16700","span":{"begin":41,"end":49},"obj":"SP_9"},{"id":"T55053","span":{"begin":125,"end":133},"obj":"GO:0051716"},{"id":"T63741","span":{"begin":134,"end":140},"obj":"UBERON:0002405;GO:0006955"},{"id":"T6035","span":{"begin":141,"end":150},"obj":"GO:0006955"},{"id":"T53384","span":{"begin":170,"end":177},"obj":"UBERON:0000912"},{"id":"T48624","span":{"begin":191,"end":199},"obj":"GO:0042571;GO:0016064"},{"id":"T90753","span":{"begin":200,"end":209},"obj":"GO:0016064"},{"id":"T38294","span":{"begin":218,"end":226},"obj":"SP_9"}],"text":"For example, immunization of mice with a MERS-CoV subunit vaccine (RBD-Fc) via the intranasal route induced higher levels of cellular immune responses and stronger local mucosal neutralizing antibody responses against MERS-CoV infection than those induced by the same vaccine via the S.C. pathway (Ma et al., 2014a)."}